leukemia chemotherapy injection – Globalstar International https://export.globalstarco.com Making Health Accessible. Thu, 05 Mar 2026 10:33:22 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://export.globalstarco.com/wp-content/uploads/2025/07/cropped-Site-Icon-32x32.png leukemia chemotherapy injection – Globalstar International https://export.globalstarco.com 32 32 Glimepiride (40 mg) https://export.globalstarco.com/product/glimepiride-40-mg/ https://export.globalstarco.com/product/glimepiride-40-mg/#respond Wed, 18 Feb 2026 10:55:03 +0000 https://export.globalstarco.com/product/glimepiride-40-mg/ Overview: Daunorubicin 20 mg Injection is a prescription chemotherapy medicine containing Daunorubicin Hydrochloride (20 mg) used primarily in the treatment of acute leukemias including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Key Benefits: – Effective in treating acute leukemias – Inhibits cancer cell DNA replication – Used in induction chemotherapy protocols Composition: Daunorubicin Hydrochloride (20 mg) How It Works: Daunorubicin works by intercalating into DNA and inhibiting topoisomerase II, which prevents DNA replication and leads to cancer cell death. Usage Instructions: – Administered only by qualified healthcare professionals – Dosage and schedule depend on treatment protocol and patient condition – Not for self administration Side Effects: – Bone marrow suppression – Nausea, vomiting, hair loss – Cardiotoxicity with long term or high dose use Precautions: – Regular monitoring of heart function and blood counts is required – Increased risk of infection and bleeding – Avoid use during pregnancy and breastfeeding unless clearly advised Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/glimepiride-40-mg/feed/ 0
Capecitabine (500 mg) https://export.globalstarco.com/product/capecitabine-500-mg/ https://export.globalstarco.com/product/capecitabine-500-mg/#respond Wed, 18 Feb 2026 10:55:02 +0000 https://export.globalstarco.com/product/capecitabine-500-mg/ Overview: Cytalon 1000 mg Injection is a chemotherapy medicine containing Cytarabine (1000 mg), primarily used in the treatment of acute myeloid leukemia (AML) and other hematological malignancies. It is administered under strict medical supervision in hospital or clinical oncology settings. Key Benefits: – Effective treatment option for acute myeloid leukemia (AML) – Inhibits cancer cell DNA synthesis and replication – Widely used in induction and consolidation chemotherapy protocols – Administered by trained healthcare professionals Composition: Cytarabine (1000 mg) How It Works: Cytarabine is an antimetabolite that interferes with DNA synthesis by inhibiting DNA polymerase. This prevents cancer cells from multiplying, leading to their destruction, particularly during the S-phase of the cell cycle. Usage Instructions: – Administered only by a qualified healthcare professional – Dosage and schedule depend on the cancer type, patient condition, and treatment protocol – Not for self-administration Side Effects: – Bone marrow suppression (low blood cell counts) – Nausea, vomiting, diarrhea – Fever, infections due to reduced immunity – Mouth sores, hair loss, fatigue Precautions: – Regular monitoring of blood counts, liver, and kidney function is required – Increased risk of infections and bleeding due to bone marrow suppression – Use effective contraception during treatment and consult doctor if pregnant or breastfeeding Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Zydus Cadila Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/capecitabine-500-mg/feed/ 0